Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DPC0T8
|
|||
| Drug Name |
XT-150
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Knee osteoarthritis [ICD-11: FA01; ICD-10: M15-M19, M47; ICD-9: 715] | Phase 2 | [1] | |
| Company |
Xalud Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04124042) A Double-Blind, Placebo-Controlled Assessment of the Tolerability and Efficacy of XT-150 for the Treatment of Moderate to Severe Pain Due to Osteoarthritis of the Knee. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Xalud Therapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.